Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms

Journal of Dermatological Science

Volumn 56, Issue 2, 2009, Pages 135-136

  Lining, Xie ^a   Uchi, Hiroshi ^a   Hayashida, Sayaka ^a   Tsuji, Gaku ^a   Kido, Makiko ^a   Nakahara, Takeshi ^a   Takeuchi, Satoshi ^a   Takahara, Masakazu ^a   Moroi, Yoichi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hypoxia inducible factor 1alpha; Hypoxia inducible factor 2alpha

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MYC PROTEIN; PARAFFIN; SURVIVIN;

BOWEN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBORRHEIC KERATOSIS; SKIN CARCINOGENESIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KERATOSIS, SEBORRHEIC; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SKIN NEOPLASMS;

EID: 70349820305     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.07.005     Document Type: Letter

References (9)

1. Zhou J., Schmid T., Schnitzer S., and Brüne B. Tumor hypoxia and cancer progression. Cancer Lett 237 (2006) 10-21
2. Rankin E.B., and Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15 (2008) 678-685
3. Dang C.V., Kim J.W., Gao P., and Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer 8 (2008) 51-56
4. Duffy M.J., O'Donovan N., Brennan D.J., Gallagher W.M., and Ryan B.M. Survivin: a promising tumor biomarker. Cancer Lett 249 (2007) 49-60
5. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 (1999) 5830-5835
6. Löfstedt T., Fredlund E., Holmquist-Mengelbier L., Pietras A., Ovenberger M., and Poellinger L. Hypoxia inducible factor-2alpha in cancer. Cell Cycle 15 6 (2007) 919-926
7. Gordan J.D., and Simon M.C. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17 (2007) 71-77
8. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J Cell Mol Med 9 (2005) 360-372
9. Ratcliffe P.J. HIF-1 and HIF-2: working alone or together in hypoxia?. J Clin Invest 117 (2007) 1068-1077